ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

4 links0 made here, not in the record6 judgments1 judge (the rules as one: Rule based)3 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06998524A Study to Assess theEfficacy and Safety ofEmicizumab in ParticipantsWith Type 3 Von WillebrandDiseaseHoffmann-La RochePhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 9 · ClinicalTrials.gov record · Version of 2026-10-09Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Nov 16 · ClinicalTrials.gov record · Version of 2026-11-16Version of 2026-11-16CONDITIONSvon Willebrand Disease, Typ…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSEmicizumabIntervention entry›As of now · Rule based · TestedTestedFactor VIIIEntry “Factor VIII (FVIII) Concentrat…›As of now · Rule based · ComparatorAs of now · Rule based · ComparatorComparatorAntihemophilic factor, huma…Entry “Factor VIII (FVIII) Concentrat…›As of now · Rule based · ComparatorAs of now · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

von Willebrand Disease, Type 3

From the registry record1 judgment on this link
Kind of condition link, from the registry to what was judged
Registryvon Willebrand Disease, Type 3, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 9The record itselfClinicalTrials.gov recordVersion of 2026-10-09Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 14von Willebrand Disease, Type 3Rule based · condition-kind ruleFinest filed termCurrent
Nov 16The record itselfClinicalTrials.gov recordVersion of 2026-11-16Record change
As of nowEmicizumabRule based · role ruleTestedCurrent
As of nowFactor VIIIRule based · role ruleComparatorCurrent
As of nowFactor VIIIRule based · role ruleComparatorCurrent
As of nowAntihemophilic factor, human recombinantRule based · role ruleComparatorCurrent
As of nowAntihemophilic factor, human recombinantRule based · role ruleComparatorCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.